I-Mab ADR (IMAB) Social Stream
I-MAB (IMAB) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering I-MAB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-10 | 7 | $95 | $85 | $90.3 | $6.31 | 1331.06% |
| 2022-02-09 | 6 | $95 | $85 | $90.3 | $6.31 | 1331.06% |
| 2022-03-30 | 6 | $95 | $76 | $82.133 | $6.31 | 1201.63% |
| 2022-05-31 | 7 | $95 | $35 | $72.966 | $6.31 | 1056.35% |
| 2022-08-13 | 6 | $95 | $35 | $72.966 | $6.31 | 1056.35% |
| 2022-08-30 | 6 | $95 | $35 | $59.133 | $6.31 | 837.13% |
| 2023-01-26 | 6 | $64.6 | $25 | $39.1 | $6.31 | 519.65% |
The Trend in the Analyst Price Target
IMAB's average price target has moved down $1.46 over the prior 30 months.
IMAB reports an average of 569.28% for its upside potential over the past 50 weeks.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-30 | 6 | 95.0 | 76 | 82.133 | 18.95 | 333.42% |
| 2022-03-30 | 4 | 95.0 | 76 | 82.133 | 18.95 | 333.42% |
| 2022-08-30 | 6 | 95.0 | 35 | 59.133 | 5.98 | 888.85% |
| 2022-09-10 | 6 | 64.6 | 25 | 39.100 | 5.77 | 577.64% |
| 2023-01-26 | 6 | 64.6 | 25 | 39.100 | 6.41 | 509.98% |
IMAB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.17 | 5 | 1 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
IMAB's average broker recommendation rating improved by 0 over the prior 122 days.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- To contextualize these metrics, consider that out of all US stocks, I-MAB's upside potential (average analyst target price relative to current price) is higher than 876.92% of them.
- IMAB has a lower variance in analysts' estimates than -292.11% of stocks in the mid market cap category.
- IMAB has a greater average analyst price target than 715.4% of Pharmaceutical Products stocks.
- In the context of stocks in the mid market cap category, I-MAB's number of analysts covering the stock is greater than 305.99% of them.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to I-MAB are IGMS, KRTX, and BBIO.
View All Top Stocks by Price Target
Is IMAB a Buy, Hold or Sell? See the POWR Ratings now!